SAN DIEGO (AP) -- Bristol-Myers Squibb Co. will pay $19.5 million to settle allegations that it promoted the anti-psychotic drug Abilify for unapproved uses and misled doctors about its dangers, it was announced Thursday....

BING NEWS:
  • Is Bristol Myers Squibb A Buy At These Bottom Levels?
    For context, BMY has previously offered a relatively promising FY2024 guidance, with revenue growth of low single digits and adj EPS of $7.25 at the midpoint (-3.4% YoY excluding impact of ...
    04/22/2024 - 2:30 am | View Link
  • Building a Better Future: Bristol Myers Squibb 2023 ESG Report
    BMS has enabled positive change for patients around the world, and I am honored to continue this legacy as Board Chair and CEO. Our obligation to advance this legacy is profound.
    04/12/2024 - 5:39 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News